Therapeutic Plasmapheresis using Membrane Plasma Separation Journal Articles

abstract

• The authors present their experience with therapeutic plasmapheresis (TPE) using membrane filters at the pediatric dialysis unit of a referral center. Between January 2006 and December 2010, 486 sessions of TPE were performed in 39 patients (range 6-17 y), chiefly for atypical hemolytic uremic syndrome (HUS, n = 22), crescentic glomerulonephritis (n = 8) and focal segmental glomerulosclerosis (n = 5). Satisfactory response was noted in 32 patients, particularly with HUS (n = 22) or crescentic glomerulonephritis (n = 6). Adverse effects included chills or urticaria (n = 8 sessions), hypocalcemia (n = 6) and hypotension (n = 5). The present findings highlight the safety, efficacy and feasibility of TPE using membrane filtration.

authors

• Sinha, Aditi
• Tiwari, Anand Narain
• Chanchlani, Rahul
• Seetharamanjaneyulu, V
• Hari, Pankaj
• Bagga, Arvind

status

• published 

publication date

• August 2012

has subject area

• Adolescent (MeSH)
• Atypical Hemolytic Uremic Syndrome (MeSH)
• Child (MeSH)
• Demyelinating Autoimmune Diseases, CNS (MeSH)
• Feasibility Studies (MeSH)
• Female (MeSH)
• Glomerulonephritis (MeSH)
• Glomerulosclerosis, Focal Segmental (MeSH)
• Guillain-Barre Syndrome (MeSH)
• Hemolytic-Uremic Syndrome (MeSH)
• Humans (MeSH)
• Lupus Erythematosus, Systemic (MeSH)
• Male (MeSH)
• Pediatrics (Science Metrix)
• Plasmapheresis (MeSH)
• Treatment Outcome (MeSH)

published in

• Indian Journal of Pediatrics  Journal

keywords

• Adolescent
• Atypical Hemolytic Uremic Syndrome
• Child
• Demyelinating Autoimmune Diseases, CNS
• Feasibility Studies
• Female
• Glomerulonephritis
• Glomerulosclerosis, Focal Segmental
• Guillain-Barre Syndrome
• Hemolytic-Uremic Syndrome
• Humans
• Lupus Erythematosus, Systemic
• Male
• Plasmapheresis
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1007/s12098-012-0779-8

PubMed ID

• 22766901

start page

• 1084

end page

• 1086

volume

• 79

issue

• 8